HR Execs on the Move

Zepp Health

www.zepp-usa.com

 
Zepp Health`s mission is to connect health with technology as a healthcare services technology company and world-leading maker of smart wearables. Since its inception in 2013, the company has developed a platform of proprietary technology including AI chips, biometric sensors, and data algorithms, which drive a broadening line of smart health products for consumers, and analytics services for the industry.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.zepp-usa.com
  • 10050 North Wolfe Road SW1-180
    Cupertino, CA USA 95014
  • Phone: 212.481.2050

Executives

Name Title Contact Details

Similar Companies

A.T. Radiology

A.T. Radiology is a diagnostic imaging provider with locations in Winter Haven, Davenport, and Lake Wales, Florida. They provide exceptional radiology and diagnostic services for patients and referring physicians throughout Florida.

Roche Insulin Delivery Systems

Roche Insulin Delivery Systems is a Fishers, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

I-Flow Corporation

I-Flow Corporation (I-Flow) is engaged in designing, developing and marketing drug delivery systems and surgical products for post-surgical pain relief and surgical site care. The CompanyÍs products are used in hospitals, free-standing surgery centers,

The Female Health Company

The Female Health Company is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alector

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.